Established on December 29, 2010 and headquartered in Xiangyang, Hubei Province, spanning more than 230 mu, Hubei Lingsheng Pharma is a professional pharmaceutical enterprise covering the R&D, production, distribution and technical services of the full oral cephalosporin antibiotic industry chain, including key intermediates, APIs and preparations such as 7-AVCA, 7-APRA, 7-ATCA, cefditoren pivoxil, cefcapene pivoxil hydrochloride, cefpodoxime proxetil and ceftibuten.

No comments available.
Leave your rating & comment